Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism
- PMID: 37589949
- DOI: 10.1210/clinem/dgad484
Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism
Abstract
Context: Few long-term randomized trials have evaluated the efficacy of testosterone replacement therapy (TRT) in improving sexual function and hypogonadal symptoms in men with hypogonadism and whether effects are sustained beyond 12 months.
Objective: The Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) study evaluated the effect of TRT on major adverse cardiovascular events in middle-aged and older men with hypogonadism. The Sexual Function Study, nested within the parent trial, determined testosterone's efficacy in improving sexual activity, hypogonadal symptoms, libido, and erectile function among men reporting low libido.
Methods: Among 5204 men, 45-80 years, with 2 testosterone concentrations <300 ng/dL, hypogonadal symptoms, and cardiovascular disease (CVD) or increased CVD risk enrolled in the TRAVERSE trial, 1161 with low libido were enrolled in the Sexual Function Study (587 randomized to receive 1.62% testosterone gel and 574 to placebo gel for the duration of their participation in the study). Primary outcome was change from baseline in sexual activity score. Secondary outcomes included hypogonadal symptoms, erectile function, and sexual desire.
Results: TRT was associated with significantly greater improvement in sexual activity than placebo (estimated mean [95% CI] between-group difference 0.49 [0.19,0.79] and 0.47 [0.11, 0.83] acts per day at 6 and 12 months, respectively; omnibus test P = .011); treatment effect was maintained at 24 months. TRT improved hypogonadal symptoms and sexual desire, but not erectile function, compared with placebo.
Conclusion: In middle-aged and older men with hypogonadism and low libido, TRT for 2 years improved sexual activity, hypogonadal symptoms, and sexual desire, but not erectile function.
Keywords: benefits of testosterone treatment; erectile dysfunction; hypogonadal symptoms; hypogonadism; low libido; sexual function; testosterone replacement therapy; testosterone treatment of older men.
© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS).J Sex Med. 2011 Nov;8(11):3204-13. doi: 10.1111/j.1743-6109.2011.02436.x. Epub 2011 Aug 11. J Sex Med. 2011. PMID: 21834870 Clinical Trial.
-
Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial.JAMA Netw Open. 2023 Oct 2;6(10):e2340030. doi: 10.1001/jamanetworkopen.2023.40030. JAMA Netw Open. 2023. PMID: 37889486 Free PMC article. Clinical Trial.
-
Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.J Sex Med. 2007 Nov;4(6):1757-62. doi: 10.1111/j.1743-6109.2006.00381.x. Epub 2006 Nov 6. J Sex Med. 2007. PMID: 17087806
-
Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores.Eur Urol. 2017 Dec;72(6):1000-1011. doi: 10.1016/j.eururo.2017.03.032. Epub 2017 Apr 20. Eur Urol. 2017. PMID: 28434676 Review.
-
Testosterone Therapy: What We Have Learned From Trials.J Sex Med. 2020 Mar;17(3):447-460. doi: 10.1016/j.jsxm.2019.11.270. Epub 2020 Jan 9. J Sex Med. 2020. PMID: 31928918 Review.
Cited by
-
[Testosterone replacement therapy and possible side effects].Urologie. 2024 Nov;63(11):1103-1110. doi: 10.1007/s00120-024-02455-8. Epub 2024 Oct 10. Urologie. 2024. PMID: 39390141 Review. German.
-
Association of serum uric acid with male sexual hormones and erectile dysfunction: a bidirectional 2-sample Mendelian randomization analysis.Sex Med. 2024 Aug 17;12(4):qfae051. doi: 10.1093/sexmed/qfae051. eCollection 2024 Aug. Sex Med. 2024. PMID: 39156235 Free PMC article.
-
Management of male obesity-related secondary hypogonadism: A clinical update.World J Exp Med. 2024 Jun 20;14(2):93689. doi: 10.5493/wjem.v14.i2.93689. eCollection 2024 Jun 20. World J Exp Med. 2024. PMID: 38948417 Free PMC article. Review.
-
The Loss of Estradiol by Androgen Deprivation in Prostate Cancer Patients Shows the Importance of Estrogens in Males.J Endocr Soc. 2024 Jun 4;8(7):bvae107. doi: 10.1210/jendso/bvae107. eCollection 2024 May 23. J Endocr Soc. 2024. PMID: 38883397 Free PMC article. Review.
-
Testosterone replacement in men with sexual dysfunction.Cochrane Database Syst Rev. 2024 Jan 15;1(1):CD013071. doi: 10.1002/14651858.CD013071.pub2. Cochrane Database Syst Rev. 2024. PMID: 38224135 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
